Cuba Advances Home-grown Cancer Drug as 2C12 Enters Human Trials

• Experimental immunotherapy modelled on PD-1 treatment to be tested in advanced melanoma patients Michael Olugbode in Abuja Cuban scientists have reached...

Read full coverage on TraceNews